Production of the Pfizer BioNTech mRNA jabs

Billions of Jabs, Trillions of Dollars projected. Let us look at what we know about the manufacturing of the Toxic Spike Protein coding packaged in the Toxic LNPs

It seems that Fifth Column operatives want to hide some of the facts about the massive taxpayer expenditure on the failed Covid19 jabs.

Here I will concentrate on Pfizer BioNTech that has achieved market dominance.

The production processes for materials used in the Phase 1 trial were not the same as those used in the Phase 2/3 trials, and most likely contributed to variations reported in Serious Adverse Events for various Lots or Batches.

The European Medicines Agency made a Major Objection¹ to Pfizer/BioNTech changing the process to use toxic E. coli instead of RT-PCR for the commercial product. Pfizer replied "as the cutoff date for the clinical Interim Analysis (IA) was changed, the IA doesn’t include data from subjects dosed with Process 2 material, and the Company does not expect to have Process 2 included in the Final Analysis dataset"

This document will be key in numerous Court cases around the world.

The same wording appears on page 57 of the EMA document.²